Combination Chemotherapy Pre-Allogeneic SCT

Pilot Study of FLAG-Ida Followed Immediately by Reduced-Intensity Allogeneic HCT for Adults Age 60 and Older With Newly Diagnosed Adverse-Risk AML or Other High-Grade Myeloid Neoplasm

More Information

Trial Status
Not yet accepting
Trial Phase
Phase 2
Enrollment
20 patients (estimated)
Sponsors
Fred Hutchinson / University of Washington Cancer Consortium
Tags
Allogeneic Stem Cell Transplant, Chemotherapy, Radiation Therapy
Trial Type
Treatment
Last Update
17 hours ago
SparkCures ID
2138
NCT Identifier
NCT07046078

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.